Paushak Ltd

Paushak Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Paushak Ltd, a micro-cap player in the specialty chemicals sector, has exhibited a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a 3.63% gain on 3 June 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages and other momentum oscillators, reflecting cautious optimism amid persistent headwinds.

Paushak Ltd, a micro-cap player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a marginal day gain of 0.20%, the stock’s broader technical indicators and price action reveal a complex picture of weakening momentum and persistent downward pressure, underscoring challenges for investors amid a tough market environment.

Paushak Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Paushak Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 May 2026, providing investors with the most recent and relevant data to assess the company’s outlook.

Paushak Limited, India's largest phosgene-based speciality chemicals manufacturer and part of the 115-year-old Alembic Group, reported a quarterly net profit of ₹12.51 crores for Q4 FY26, marking a sequential improvement of 102.76% quarter-on-quarter and 30.31% year-on-year growth. However, the headline numbers conceal underlying operational challenges, with operating margins contracting and an unusually high contribution from other income raising questions about earnings quality. The stock, trading at ₹500.15 with a market capitalisation of ₹1,233.22 crores, declined 1.57% following the results announcement, reflecting investor scepticism about the sustainability of the profit surge.

Paushak Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 May 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.

Paushak Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 22 April 2026, providing investors with an up-to-date view of the stock’s performance and outlook.

Paushak Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 April 2026, providing investors with the latest insights into its performance and outlook.

Paushak Ltd, a micro-cap player in the Specialty Chemicals sector, has exhibited a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a robust day gain of 6.15% to close at ₹454.95, the stock’s broader technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these technical parameters in detail, placing the stock’s recent price action in context with its historical performance and sector benchmarks.

Paushak Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 31 March 2026, providing investors with the latest insights into its performance and outlook.

For the second consecutive day, Paushak Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 346.1 on 30 Mar 2026. This decline extends a recent losing streak that has seen the stock shed over 10.5% in just two sessions, underperforming its sector and the broader market.

For the fifth consecutive session, Paushak Ltd closed lower, hitting a fresh 52-week low of Rs 369 on 27 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper than its sector peers.

For the third consecutive session, Paushak Ltd has closed lower, culminating in a fresh 52-week low of Rs 392.15 on 23 Mar 2026. This decline extends the stock’s year-long underperformance, with a drop of 18.31% compared to the Sensex’s 5.43% fall over the same period.

For the third consecutive session, Paushak Ltd has declined, culminating in a fresh 52-week low of Rs 392.15 on 23 Mar 2026. This marks a significant drop from its 52-week high of Rs 991.20, reflecting a sustained period of selling pressure amid broader market weakness.

Paushak Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Paushak Ltd, a micro-cap player in the Specialty Chemicals sector, recorded a fresh 52-week low of Rs.398 today, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and benchmark indices.